Moderna Q3 preview: What to expect
Moderna (MRNA) is scheduled to announce Q3 earnings results on November 6, before market open, with analysts’ consensus pointing to another quarter of losses. Analysts have projected a loss of -$2.16 per share for the quarter, while revenue is likely...
Seeking Alpha